Volume 18, Issue 4 pp. 645-648
Short Paper
Full Access

Selective stimulation of human t lymphocyte subsets by heteroconjugates of antibodies to the t cell receptor and to subset-specific differentiation antigens

Frank Emmrich

Corresponding Author

Frank Emmrich

Max-Planck-Society, Research Unit for Rheumatology/Immunology, Erlangen

Max-Planck-Gesellschaft, Klinische Arbeitsgruppe für Rheumatologie/Immunologie am Institut für Klinische Immunologie und Rheumatologie der Universität Erlangen-Nürnberg, Schwabachanlage 10, D-8520 Erlangen, FRGSearch for more papers by this author
Peter Rieber

Peter Rieber

Institute for Immunology of the University of Munich, Munich

Search for more papers by this author
Roland Kurrle

Roland Kurrle

Behringwerke, Marburg

Search for more papers by this author
Klaus Eichmann

Klaus Eichmann

Max-Planck-Institute for Immunobiology, Freiburg

Search for more papers by this author
First published: April 1988
Citations: 16

Abstract

Ligand binding under conditions that generate microaggregates of the T cell receptor complex (Ti/CD3) with the membrane molecules CD4 or CD8 can induce activation of small resting T lymphocytes. We demonstrate this by using soluble dimeric heteroconjugates consisting of monoclonal antibodies to CD4/CD8 and of a novel anti-CD3 monoclonal antibody (BMA 030) which even in aggregated form is not stimulatory on its own under limiting conditions in the absence of accessory cells. Using combinations of BMA 030 with either anti-CD4 or anti-CD8, the corresponding T cell sub-population could be selectively expanded in vitro. Selective expansion of T cell sub-populations in vitro or in vivo might be helpful for certain therapeutical manipulations. In addition, this finding may contribute to a better understanding of major histocompatibility complex-restricted T cell activation.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.